Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.

Jabbari E, Woodside J, Tan MMX, Pavese N, Bandmann O, Ghosh BCP, Massey LA, Capps E, Warner TT, Lees AJ, Revesz T, Holton JL, Williams NM, Grosset DG, Morris HR.

Mov Disord. 2019 Jul 12. doi: 10.1002/mds.27786. [Epub ahead of print]

PMID:
31299107
2.

Saccadic Direction Errors are Associated with Impulsive Compulsive Behaviours in Parkinson's Disease Patients.

Barbosa P, Kaski D, Castro P, Lees AJ, Warner TT, Djamshidian A.

J Parkinsons Dis. 2019 Jul 1. doi: 10.3233/JPD-181460. [Epub ahead of print]

PMID:
31282422
3.

Clinical presentations of Wilson disease.

Shribman S, Warner TT, Dooley JS.

Ann Transl Med. 2019 Apr;7(Suppl 2):S60. doi: 10.21037/atm.2019.04.27. Review.

4.

Training in neurology: lessons learnt.

Shribman S, Alexander SK, Zarkali A, Warner TT, Pereira AC, Hughes TAT, Mummery CJ.

Pract Neurol. 2019 May 13. pii: practneurol-2018-002129. doi: 10.1136/practneurol-2018-002129. [Epub ahead of print]

PMID:
31085719
5.

Neuropathological progression of clinical Parkinson disease subtypes.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT.

Nat Rev Neurol. 2019 Jun;15(6):361. doi: 10.1038/s41582-019-0197-x. No abstract available.

PMID:
31048772
6.

Review: Clinical, neuropathological and genetic features of Lewy body dementias.

Hansen D, Ling H, Lashley T, Holton JL, Warner TT.

Neuropathol Appl Neurobiol. 2019 Apr 12. doi: 10.1111/nan.12554. [Epub ahead of print] Review.

PMID:
30977926
7.

Copy number variation of LINGO1 in familial dystonic tremor.

Alakbarzade V, Iype T, Chioza BA, Singh R, Harlalka GV, Hardy H, Sreekantan-Nair A, Proukakis C, Peall K, Clark LN, Caswell R, Lango Allen H, Wakeling M, Chilton JK, Baple EL, Louis ED, Warner TT, Crosby AH.

Neurol Genet. 2019 Feb 4;5(1):e307. doi: 10.1212/NXG.0000000000000307. eCollection 2019 Feb.

8.

The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.

Barbosa PM, Djamshidian A, O'Sullivan SS, de Pablo-Fernandez E, Korlipara P, Morris HR, Bhatia KP, Limousin P, Foltynie T, Lees AJ, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 Feb 1. pii: jnnp-2018-319891. doi: 10.1136/jnnp-2018-319891. [Epub ahead of print] No abstract available.

PMID:
30709896
9.

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2019 Jan 14. doi: 10.1001/jamaneurol.2018.4377. [Epub ahead of print]

PMID:
30640364
10.

Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy.

Oliveira MCB, Ling H, Lees AJ, Holton JL, De Pablo-Fernandez E, Warner TT.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):555-561. doi: 10.1136/jnnp-2018-319374. Epub 2018 Dec 31.

PMID:
30598430
11.

Reply to: Young- onset multiple system atrophy.

Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP.

Mov Disord. 2018 Dec;33(12):1975-1976. doi: 10.1002/mds.27572. No abstract available.

PMID:
30578697
12.

Neuropathology of Circadian Alterations in Parkinson Disease-Reply.

De Pablo-Fernández E, Warner TT, Holton JL.

JAMA Neurol. 2018 Dec 3. doi: 10.1001/jamaneurol.2018.3758. [Epub ahead of print] No abstract available.

PMID:
30508142
13.

The Outcome of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Retrospective Postmortem Study.

Barbosa P, Djamshidian A, Lees AJ, Warner TT.

Mov Disord Clin Pract. 2018 Oct 4;5(5):519-522. doi: 10.1002/mdc3.12671. eCollection 2018 Sep-Oct.

PMID:
30515441
14.

Dystonia.

Barbosa P, Warner TT.

Handb Clin Neurol. 2018;159:229-236. doi: 10.1016/B978-0-444-63916-5.00014-8. Review.

PMID:
30482316
15.

Delineating cerebellar mechanisms in DYT11 myoclonus-dystonia.

Sadnicka A, Galea JM, Chen JC, Warner TT, Bhatia KP, Rothwell JC, Edwards MJ.

Mov Disord. 2018 Dec;33(12):1956-1961. doi: 10.1002/mds.27517. Epub 2018 Oct 17.

PMID:
30334277
16.

Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate.

Magdalinou NK, Golden HL, Nicholas JM, Witoonpanich P, Mummery CJ, Morris HR, Djamshidian A, Warner TT, Warrington EK, Lees AJ, Warren JD.

Neurocase. 2018 Aug;24(4):204-212. doi: 10.1080/13554794.2018.1527368. Epub 2018 Oct 6.

17.

Young-onset multiple system atrophy: Clinical and pathological features.

Batla A, De Pablo-Fernandez E, Erro R, Reich M, Calandra-Buonaura G, Barbosa P, Balint B, Ling H, Islam S, Cortelli P, Volkmann J, Quinn N, Holton JL, Warner TT, Bhatia KP.

Mov Disord. 2018 Jul;33(7):1099-1107. doi: 10.1002/mds.27450.

PMID:
30153390
18.

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.

Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Müller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Höglinger GU, Holton JL, Ryten M, Morris HR.

Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.

19.

Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.

Mamais A, Manzoni C, Nazish I, Arber C, Sonustun B, Wray S, Warner TT, Cookson MR, Lewis PA, Bandopadhyay R.

Brain Res. 2018 Dec 15;1701:75-84. doi: 10.1016/j.brainres.2018.07.023. Epub 2018 Jul 25.

20.

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.

De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT.

Neurology. 2018 Jul 10;91(2):e139-e142. doi: 10.1212/WNL.0000000000005771. Epub 2018 Jun 13.

PMID:
29898968
21.

Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy.

Foley JA, Niven EH, Paget A, Bhatia KP, Farmer SF, Jarman PR, Limousin P, Warner TT, Morris HR, Bak TH, Abrahams S, Cipolotti L.

Parkinsons Dis. 2018 May 9;2018:2426012. doi: 10.1155/2018/2426012. eCollection 2018.

22.

Autonomic Dysfunction in Parkinson's Disease: The Hidden Game Changer?

De Pablo-Fernandez E, Warner TT.

Mov Disord. 2018 Jul;33(6):1028. doi: 10.1002/mds.27422. Epub 2018 May 14. No abstract available.

PMID:
29756259
23.

A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

De Pablo-Fernández E, Courtney R, Warner TT, Holton JL.

JAMA Neurol. 2018 Aug 1;75(8):1008-1012. doi: 10.1001/jamaneurol.2018.0640.

24.

Phenotypes, genotypes, and the management of paroxysmal movement disorders.

Silveira-Moriyama L, Kovac S, Kurian MA, Houlden H, Lees AJ, Walker MC, Roze E, Paciorkowski AR, Mink JW, Warner TT.

Dev Med Child Neurol. 2018 Jun;60(6):559-565. doi: 10.1111/dmcn.13744. Epub 2018 Mar 30. Review.

25.

No evidence of iatrogenic human transmission in autopsy confirmed multiple system atrophy.

De Pablo-Fernandez E, Cerdán Santacruz D, Warner TT, Holton JL.

Mov Disord. 2018 Jul;33(7):1183-1184. doi: 10.1002/mds.27370. Epub 2018 Mar 23. No abstract available.

PMID:
29570847
26.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
27.

Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.

Barbosa PM, Grippe T, Lees AJ, O'Sullivan S, Djamshidian A, Warner TT.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1121-1123. doi: 10.1136/jnnp-2017-317298. Epub 2017 Nov 24. No abstract available.

PMID:
29175897
28.

The neuropsychological profile of Othello syndrome in Parkinson's disease.

Foley JA, Warner TT, Cipolotti L.

Cortex. 2017 Nov;96:158-160. doi: 10.1016/j.cortex.2017.08.009. Epub 2017 Aug 16. No abstract available.

PMID:
28917380
29.

Dystonia.

De Pablo-Fernandez E, Warner TT.

Br Med Bull. 2017 Sep 1;123(1):91-102. doi: 10.1093/bmb/ldx019. Review.

PMID:
28910989
30.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T.

Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3.

31.

Iatrogenic B12-deficient peripheral neuropathy following nitrous oxide administration for functional tonic leg spasm: A case report.

Kaski D, Kumar P, Murphy E, Warner TT.

Clin Neurol Neurosurg. 2017 Sep;160:108-110. doi: 10.1016/j.clineuro.2017.07.006. Epub 2017 Jul 6. No abstract available.

PMID:
28709008
32.

Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease.

De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT.

JAMA Neurol. 2017 Aug 1;74(8):970-976. doi: 10.1001/jamaneurol.2017.1125.

33.

Nomenclature of genetic movement disorders: Recommendations of the International Parkinson and Movement Disorder Society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2017 May;32(5):724-725. doi: 10.1002/mds.27045. No abstract available.

PMID:
28513081
34.

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmén-Larsson J, Holtta M, Blennow K, Morris HR, Skillbäck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J.

Parkinsonism Relat Disord. 2017 Apr;37:65-71. doi: 10.1016/j.parkreldis.2017.01.016. Epub 2017 Jan 31.

PMID:
28214264
35.

Hypothalamic α-synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease.

De Pablo-Fernandez E, Courtney R, Holton JL, Warner TT.

Mov Disord. 2017 Feb;32(2):296-298. doi: 10.1002/mds.26868. Epub 2016 Nov 28. No abstract available.

PMID:
27892607
36.

Neuroendocrine abnormalities in Parkinson's disease.

De Pablo-Fernández E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):176-185. doi: 10.1136/jnnp-2016-314601. Epub 2016 Oct 31. Review.

PMID:
27799297
37.

Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology.

Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T.

Brain. 2016 Dec;139(Pt 12):3237-3252. Epub 2016 Oct 25.

PMID:
27797812
38.

Reply letter to Jinnah "Locus pocus" and Albanese "Complex dystonia is not a category in the new 2013 consensus classification": Necessary evolution, no magic!

Klein C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Kostic V, Lohmann K, Marras C; International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders.

Mov Disord. 2016 Nov;31(11):1760-1762. doi: 10.1002/mds.26763. Epub 2016 Sep 13. No abstract available.

PMID:
27619077
39.

A Retrospective Evaluation of the Frequency of Impulsive Compulsive Behaviors in Parkinson's Disease Patients Treated with Continuous Waking Day Apomorphine Pumps.

Barbosa P, Lees AJ, Magee C, Djamshidian A, Warner TT.

Mov Disord Clin Pract. 2016 Aug 11;4(3):323-328. doi: 10.1002/mdc3.12416. eCollection 2017 May-Jun.

40.

MSA-C or SCA 17? A clinicopathological case update.

Doherty KM, De Pablo-Fernandez E, Houlden H, Polke JM, Lees AJ, Warner TT, Holton JL.

Mov Disord. 2016 Oct;31(10):1582-1584. doi: 10.1002/mds.26741. No abstract available.

PMID:
27477540
41.

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.

Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C.

Mov Disord. 2016 Apr;31(4):436-57. doi: 10.1002/mds.26527. Review.

PMID:
27079681
42.

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM, Noyce AJ, Mencacci NE, Lubbe SJ; International Parkinson's Disease Genomics Consortium (IPDGC), Williams-Gray CH, Barker RA, van Dijk KD, Berendse HW, Heutink P, Corvol JC, Cormier F, Lesage S, Brice A, Brockmann K, Schulte C, Gasser T, Foltynie T, Limousin P, Morrison KE, Clarke CE, Sawcer S, Warner TT, Lees AJ, Morris HR, Nalls MA, Singleton AB, Hardy J, Abramov AY, Plagnol V, Williams NM, Wood NW.

Lancet Neurol. 2016 May;15(6):585-96. doi: 10.1016/S1474-4422(16)00071-5. Epub 2016 Mar 24.

43.

Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.

McCourt AC, Parker J, Silajdžić E, Haider S, Sethi H, Tabrizi SJ, Warner TT, Björkqvist M.

J Huntingtons Dis. 2015;4(4):371-82. doi: 10.3233/JHD-150172.

PMID:
26756592
44.

A Metabolic Study of Huntington's Disease.

Nambron R, Silajdžić E, Kalliolia E, Ottolenghi C, Hindmarsh P, Hill NR, Costelloe SJ, Martin NG, Positano V, Watt HC, Frost C, Björkqvist M, Warner TT.

PLoS One. 2016 Jan 8;11(1):e0146480. doi: 10.1371/journal.pone.0146480. eCollection 2016.

45.

Systematic review and meta-analysis of salivary protein concentration in Parkinson's disease.

Masters JM, Bestwick J, Warner TT, Giovannoni G, Proctor GB, Noyce AJ.

Mov Disord. 2015 Dec;30(14):1971-2. doi: 10.1002/mds.26462. Epub 2015 Nov 19. Review. No abstract available.

PMID:
26583568
46.

A large Indian family with rearrangement of chromosome 4p16 and 3p26.3 and divergent clinical presentations.

Iype T, Alakbarzade V, Iype M, Singh R, Sreekantan-Nair A, Chioza BA, Mohapatra TM, Baple EL, Patton MA, Warner TT, Proukakis C, Kulkarni A, Crosby AH.

BMC Med Genet. 2015 Nov 10;16:104. doi: 10.1186/s12881-015-0251-5.

47.

Erratum to: Strategies for treatment of dystonia.

Dressler D, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Saberi FA.

J Neural Transm (Vienna). 2016 Mar;123(3):259. doi: 10.1007/s00702-015-1471-8. No abstract available.

PMID:
26546035
48.

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.

Kalliolia E, Silajdžić E, Nambron R, Costelloe SJ, Martin NG, Hill NR, Frost C, Watt HC, Hindmarsh P, Björkqvist M, Warner TT.

PLoS One. 2015 Oct 2;10(10):e0138848. doi: 10.1371/journal.pone.0138848. eCollection 2015.

49.

Strategies for treatment of dystonia.

Dressler D, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Frucht S, Garcia-Ruiz PJ, Kaelin A, Kaji R, Kanovsky P, Laskawi R, Micheli F, Orlova O, Relja M, Rosales R, Slawek J, Timerbaeva S, Warner TT, Saberi FA.

J Neural Transm (Vienna). 2016 Mar;123(3):251-8. doi: 10.1007/s00702-015-1453-x. Epub 2015 Sep 14. Erratum in: J Neural Transm (Vienna). 2016 Mar;123(3):259.

PMID:
26370676
50.

Effects of age and cognition on a cross-cultural paediatric adaptation of the Sniffin' Sticks Identification Test.

Bastos LO, Guerreiro MM, Lees AJ, Warner TT, Silveira-Moriyama L.

PLoS One. 2015 Aug 12;10(8):e0131641. doi: 10.1371/journal.pone.0131641. eCollection 2015.

Supplemental Content

Loading ...
Support Center